Retatrutide
Retatrutide is an experimental peptide that activates three hormone receptors: GLP‑1, GIP and glucagon. Together, these pathways help reduce appetite, regulate blood sugar and influence how the body uses energy, supporting weight loss. It is still being studied and is not yet approved for public use
The batch you'll receive (BH-RET-261005-01) was tested by our independent partner lab before it went on sale.
● In stock
ℹ️ For information only – not medical advice. Investigational products, not registered medicines. Speak to a doctor before using any product. Safety first · Learn more
Trial results simulatorSee what the average trial results would mean for your weight Ask a question about this product- Encrypted checkout with Yoco
- Free delivery on orders over R750.00
- Dispatched within 1–2 working days
Watch & learn
About this product
Retatrutide is an experimental peptide that activates three hormone receptors—GLP‑1, GIP and glucagon—involved in appetite, blood sugar and energy use. Human trials have shown substantial weight loss. It remains investigational and is not yet approved for public use. www.lilly.com
The percentages below measure total body weight lost, not body-fat percentage:
Human study Duration Average body-weight loss by weekly study dose Placebo
Phase 2 obesity trial, 2023 48 weeks 1 mg: 8.7% · 4 mg: 17.1% · 8 mg: 22.8% · 12 mg: 24.2% 2.1%
Phase 3 TRIUMPH‑4: obesity with knee osteoarthritis 68 weeks 9 mg: 26.4% · 12 mg: 28.7% 2.1%
Phase 3 TRIUMPH‑1: obesity without diabetes 80 weeks 4 mg: 19.0% · 9 mg: 25.9% · 12 mg: 28.3% 2.2%
Sources: published Phase 2 trial and Lilly’s Phase 3 reports. New England Journal of Medicine
In a selected TRIUMPH‑1 extension group, average weight loss reached 30.3% after 104 weeks. These participants had completed the main trial and tolerated treatment. Lilly India
These are study averages, not guaranteed results or dosing recommendations. The Phase 3 figures above estimate outcomes assuming continued treatment; TRIUMPH‑1’s analysis including treatment interruptions and discontinuations reported 25.0% loss at 12 mg, versus 28.3%.
How to mix
This product comes as a dry powder and must be mixed (reconstituted) before use. Watch the video for the full step-by-step method.
- Work on a clean surface and wash your hands first
- Wipe the vial tops with an alcohol swab
- Add the liquid slowly down the side of the vial – don't spray it onto the powder
- Gently swirl until dissolved – don't shake
- Follow the storage instructions once mixed
Questions about mixing? Ask us.
How to use
Attached is some you tube videos about Retatrutide please do your own research there are multiple videos explaining exactly what the peptide is how to mix and how to dose. Everything you need is online.
Research & evidence
Human trials & test results
Links open external websites. Research is shared for information only – it is not a claim that this product diagnoses, treats or cures any condition. Talk to a healthcare professional before use.